Department of Medicine, Yale University, 333 Cedar St., 1080 LMP, New Haven, CT 06520, USA.
Am J Physiol Gastrointest Liver Physiol. 2012 Oct;303(7):G851-60. doi: 10.1152/ajpgi.00520.2011. Epub 2012 Jul 19.
Lymphocyte numbers are tightly regulated; with acute lymphopenia, T cell numbers are reestablished through lymphopenia-induced proliferation. In contrast to the costimulation requirements of antigen-driven proliferation, a number of costimulatory molecules are not required for lymphopenia-induced proliferation. However, the requirement for major histocompatibility complex (MHC)-T cell receptor (TCR) interactions and the enhanced lymphopenia-induced proliferation in T cells with higher TCR affinity argue for a role for surface molecules that contribute to efficient MHC-TCR interactions, in particular adhesion molecules. CD18 is an integrin that contributes to the activation of peripheral and intestinal T cells through adhesive and costimulatory mechanisms. We found that CD18 is required for optimal polyclonal and monoclonal CD4+ T cell lymphopenia-induced proliferation in recombination-activating gene 1-deficient (RAG-1-/-) mice; this requirement persisted over time. Uniquely, the dependency on CD18 in CD4+ T cells is in the rapid proliferation in RAG-1-/- recipients and in the slow homeostatic proliferation in irradiated Balb/c recipients. Consistent with the proposed role for intestinal microbiota in lymphopenia-induced rapid proliferation in RAG-/- mice, we observed a significant reduction in rapid proliferation upon treatment of mice with antibiotics; however, the dependency on CD18 for optimal lymphopenia-induced proliferation persisted. Moreover, the dependency for CD18 is maintained over a wide range of numbers of initially transferred T cells, including a low number of initially transferred T cells, when the drive for proliferation is very strong and proliferation is more rapid. Overall, these data argue for an essential and broad role for CD18 in lymphopenia-induced proliferation.
淋巴细胞数量受到严格调控;急性淋巴细胞减少症时,T 细胞数量通过淋巴细胞减少诱导的增殖得以恢复。与抗原驱动增殖的共刺激要求不同,许多共刺激分子不是淋巴细胞减少诱导增殖所必需的。然而,主要组织相容性复合体(MHC)-T 细胞受体(TCR)相互作用的要求以及具有更高 TCR 亲和力的 T 细胞中增强的淋巴细胞减少诱导增殖表明,表面分子在促进有效 MHC-TCR 相互作用方面发挥作用,特别是粘附分子。CD18 是一种整合素,通过粘附和共刺激机制促进外周和肠道 T 细胞的激活。我们发现,CD18 是重组激活基因 1 缺陷(RAG-1-/-)小鼠多克隆和单克隆 CD4+T 细胞淋巴细胞减少诱导增殖的最佳所需;这种需求随着时间的推移而持续。独特的是,CD18 在 CD4+T 细胞中的依赖性在于 RAG-1-/-受者中的快速增殖和辐照 Balb/c 受者中的缓慢同源性增殖。与肠道微生物群在 RAG-/-小鼠淋巴细胞减少诱导快速增殖中的拟议作用一致,我们观察到在用抗生素治疗小鼠时,快速增殖显著减少;然而,对于最佳淋巴细胞减少诱导增殖的 CD18 依赖性仍然存在。此外,对于 CD18 的依赖性在最初转移的 T 细胞数量的广泛范围内得到维持,包括当增殖驱动力非常强且增殖更快时,最初转移的 T 细胞数量较低。总体而言,这些数据表明 CD18 在淋巴细胞减少诱导增殖中具有重要且广泛的作用。